This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Andrew J. Scheman, MD; Maria D. Hordinsky, MD; David W. Groth, MD; Gregory M. Vercellotti, MD; Kristin M. Leiferman, MD

Arch Dermatol. 1989;125(8):1079-1083.

Abstract
• Herpes gestationis is a pregnancy-related bullous dermatosis of unknown origin with associated tissue and peripheral blood eosinophilia. In this report, eosinophil degranulation in herpes gestationis was studied, and the role that the eosinophil may have as an effector cell that induces tissue damage through deposition of toxic cationic proteins is discussed. Using indirect immunofluorescence with antibody to human eosinophil granule major basic protein, major basic protein was observed both within tissue eosinophils and deposited extracellularly outside eosinophils in the dermis of eight patients with herpes gestationis. Possible mechanisms whereby eosinophils might be activated to degranulate in herpes gestationis are reviewed.

(Arch Dermatol. 1989;125:1079-1083)

Author Affiliations
From the Departments of Dermatology (Drs Scheman, Hordinsky, and Groth) and Hematology (Dr Vercellotti), University of Minnesota, Minneapolis, and the Department of Dermatology, Mayo Clinic and Mayo Foundation, Rochester, Minn (Dr Leiferman). Dr Scheman is now with the Department of Dermatology, The Johns Hopkins Medical Institutions and Francis Scott Key Medical Center, Baltimore, Md.

Footnotes
Accepted for publication December 29, 1988.

Presented in part at the Society of Investigative Dermatology Meeting, Washington, DC, April 27, 1988.

Reprint requests to Department of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (Dr Leiferman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?